National pharmacare has once again arisen as a major issue in Canada. This report assesses five models for achieving universal coverage against how well they might improve access to medicines, value for money, and the patient and provider experience.
Assessing the Options for Pharmacare Reform in Canada
Assessing the Options for Pharmacare Reform in Canada
Health and Healthcare
$0.00
Over the past several decades, numerous options for pharmacare reform in Canada have been studied and discussed. In the course of this debate, there have been many ideas and little consensus.
At present, almost every Canadian is enrolled in or eligible for some form of publicly funded prescription drug coverage. However, this coverage varies considerably across regions and can be confusing for patients, caregivers, and prescribers. Every province and territory has asserted their jurisdiction over health care and developed their own unique publicly funded prescription medication insurance plans.
This report reviews several major proposed models for pharmacare reform as part of Signal49 Research’s National Pharmacare Initiative.
Customers Who Downloaded This Also Liked
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
